{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:31:16Z","timestamp":1780446676456,"version":"3.54.1"},"reference-count":60,"publisher":"Termedia Sp. z.o.o.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatologia"],"published-print":{"date-parts":[[2020,10,13]]},"abstract":"<jats:p>Liver involvement in rheumatic diseases may occur as a primary liver disease, primary rheumatic disease with hepatic manifestations or antirheumatic drug-induced liver disease. The aim of our article is to underline the importance of monitoring and control of the level of aminotransferases and cholestatic enzymes in rheumatic  disorders. Some of the rheumatic diseases with constantly elevated liver enzymes need to be investigated in consideration of concomitant primary autoimmune liver disease (such as autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis) or drug hepatotoxicity. Also, we should be aware of hepatitis B reactivation or hepatitis C flare when immunosuppressants are used.<\/jats:p>","DOI":"10.5114\/reum.2020.99782","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T12:35:55Z","timestamp":1605530155000},"page":"289-296","source":"Crossref","is-referenced-by-count":11,"title":["Liver involvement in rheumatic diseases"],"prefix":"10.5114","volume":"58","author":[{"given":"Joanna","family":"Podg\u00f3rska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Werel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Klapaczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Orzechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Wudarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Gietka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"ref-780004","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi M","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, et al. (1992). Preliminary criteria for classification of adult Still\u2019s disease J Rheumatol. 19: 424-430.","journal-title":"J Rheumatol"},{"key":"ref-780005","doi-asserted-by":"publisher","DOI":"10.1007\/s005350200098"},{"key":"ref-780006","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2000.020005366.x"},{"key":"ref-780007","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200210000-00012"},{"key":"ref-780008","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2002.001826"},{"key":"ref-780009","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(56)91483-0"},{"key":"ref-780010","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930"},{"key":"ref-780011","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80297-9"},{"key":"ref-780012","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.9458"},{"key":"ref-780013","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260306"},{"key":"ref-780014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.12.012"},{"key":"ref-780015","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"ref-780016","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.1.78"},{"key":"ref-780017","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20732"},{"key":"ref-780018","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608895"},{"key":"ref-780019","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080336"},{"key":"ref-780020","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes G","year":"1986","unstructured":"Hughes G, Harris EN, Gharavi A. (1986). The anticardiolipin syndrome J Rheumatol. 13: 486-489.","journal-title":"J Rheumatol"},{"key":"ref-780021","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91477-4"},{"key":"ref-780022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"ref-780023","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0409"},{"key":"ref-780024","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem158"},{"key":"ref-780025","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199807000-00021"},{"key":"ref-780026","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2010.09.006"},{"key":"ref-780027","doi-asserted-by":"publisher","DOI":"10.1136\/ard.37.5.428"},{"key":"ref-780028","doi-asserted-by":"publisher","DOI":"10.1177\/003693308002500104"},{"key":"ref-780029","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.05.002"},{"key":"ref-780030","doi-asserted-by":"publisher","DOI":"10.1136\/ard.37.2.183"},{"key":"ref-780031","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(01)00238-0"},{"key":"ref-780032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.10.035"},{"key":"ref-780033","doi-asserted-by":"publisher","DOI":"10.1002\/art.39859"},{"key":"ref-780034","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200207000-00003"},{"key":"ref-780035","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230x-2-21"},{"key":"ref-780036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)31920-9","article-title":"Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sj\u00f6gren\u2019s syndrom","volume":"6","author":"Monta\u0144o-Loza AJ","year":"2007","unstructured":"Monta\u0144o-Loza AJ, Crisp\u00edn-Acu\u0144a JC, Remes-Troche JM, et al. (2007). Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sj\u00f6gren\u2019s syndrom Ann Hepatol. 6: 150-155.","journal-title":"Ann Hepatol"},{"key":"ref-780037","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.06.016"},{"key":"ref-780038","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00918090","article-title":"Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases","volume":"12","author":"Zurgil N","year":"1992","unstructured":"Zurgil N, Bakimer R, Moutsopoulos HM, et al. (1992). Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases J Clin Immunol. 12: 201-209.","journal-title":"J Clin Immunol"},{"key":"ref-780039","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.11.005"},{"key":"ref-780040","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.8.745"},{"key":"ref-780041","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"ref-780042","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.11.004"},{"key":"ref-780043","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.075002"},{"key":"ref-780044","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/976427"},{"key":"ref-780045","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2013.04.005"},{"key":"ref-780046","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.03.310"},{"key":"ref-780047","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"ref-780048","doi-asserted-by":"publisher","DOI":"10.1002\/art.20401"},{"key":"ref-780049","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199509000-00002"},{"key":"ref-780050","first-page":"858","article-title":"Budd-Chiari syndrome: a common complication of Beh\u00e7et\u2019s disease","volume":"92","author":"Bayraktar Y","year":"1997","unstructured":"Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. (1997). Budd-Chiari syndrome: a common complication of Beh\u00e7et\u2019s disease Am J Gastroenterol. 92: 858-862.","journal-title":"Am J Gastroenterol"},{"key":"ref-780051","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1982.tb03212.x"},{"key":"ref-780052","first-page":"645","volume-title":"Hepatic injury due to drugs, herbal compounds, chemicals and toxins. In: MacSween\u2019s Pathology of the Liver","author":"Burt AD","year":"2012","unstructured":"Burt AD, Portmann BC, Ferrell LD, Lewis JH, Kleiner DE. (2012). Hepatic injury due to drugs, herbal compounds, chemicals and toxins. In: MacSween\u2019s Pathology of the Liver, 6th. 645-760. Churchill Livingstone Elsevier, Edinburgh.","edition":"6th"},{"key":"ref-780053","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"Visser K","year":"2009","unstructured":"Visser K, van der Heijde DM. (2009). Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature Clin Exp Rheumatol. 27: 1017-1025.","journal-title":"Clin Exp Rheumatol"},{"key":"ref-780054","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094474"},{"key":"ref-780055","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370304"},{"key":"ref-780056","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101378"},{"key":"ref-780057","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.7.686"},{"key":"ref-780058","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref-780059","first-page":"1944","article-title":"Safety of anti-tumor necrosis factor-\u03b1 therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection","volume":"35","author":"Ferri C","year":"2008","unstructured":"Ferri C, Ferraccioli G, Ferrari D, et al. (2008). Safety of anti-tumor necrosis factor-\u03b1 therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection J Rheumatol. 35: 1944-1949.","journal-title":"J Rheumatol"},{"key":"ref-780060","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0169-y"},{"key":"ref-780061","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.025"},{"key":"ref-780062","doi-asserted-by":"publisher","DOI":"10.1002\/art.40176"},{"key":"ref-780063","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130683"}],"container-title":["Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/reu.termedia.pl\/pdf-127756-85929","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reu.termedia.pl\/pdf-127756-85929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T08:02:30Z","timestamp":1674806550000},"score":1,"resource":{"primary":{"URL":"https:\/\/reu.termedia.pl\/Liver-involvement-in-rheumatic-diseases,127756,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["127756"],"URL":"https:\/\/doi.org\/10.5114\/reum.2020.99782","relation":{},"ISSN":["0034-6233","2084-9834"],"issn-type":[{"value":"0034-6233","type":"print"},{"value":"2084-9834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}